Pulmonary immunotoxic potentials of metals are governed by select physicochemical properties: Chromium agents

Mitchell D. Cohen, Colette M. Prophete, Maureen Sisco, Lung Chi Chen, Judith Zelikoff, Jason J. Smee, Alvin A. Holder, Debbie C. Crans

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Increasing the understanding of how metal ions/complexes react in situ will allow for the improved specificity and controlled toxicity of novel synthetic metallocompounds that will be used as inhaled diagnostics or therapeutics. Our previous work showed that inhalation of select metals (e.g., chromium, vanadium, nickel, iron) caused alterations in lung immune cell function and in local bacterial resistance. The data also suggested that variations in the degree of immuno-modulation induced were not solely dependent on the amount of metal deposited in the lung, but also on the specific compound. If specificity governs immunomodulatory potential, it follows that physicochemical properties inherent to the metal may have a role in the elicited effects. We hypothesize that major determinants of any metal compound's immunomodulatory potential in situ are its redox behavior, valency, and/or solubility. Using changes in local bacterial resistance as an endpoint, differences in immunotoxic potential in the lungs were quantified for a range of chromium agents (insoluble calcium chromate(VI), and soluble sodium chromate(VI), potassium bis(dipicolinato)chromate(III) and sodium bis(dipicolinato)chromate(II)). Results indicated that among the latter three forms of Cr, strongly oxidizing hexavalent Cr (Cr[VI]) had the greatest impact on resistance, while reducing divalent and fairly unreactive trivalent forms of Cr had no effect at an equal exposure level (i.e., 100 μ g Cr/m 3 , 5 hr/d, for 5 d). Insoluble Cr(VI) had a greater effect than its soluble form. When data was analyzed in the context of pre-infection lung Cr burdens, it was seen that immunomodulatory potentials for both Cr(VI) agents did not differ significantly; however, complexes with different oxidation states did induce varying responses, suggesting that differences in potential might be attributed to redox behavior. From this it was concluded that for Cr, certain physicochemical properties are likely more important to any in situ pulmonary immunotoxicity than others (i.e., redox behavior is more critical than solubility). Our findings, in part, will help provide a basis for understanding why certain metals could be a greater health risk than others, even when encountered in equal amounts. This, in turn, will help researchers in the design of inhalable diagnostic/therapeutic metallopharmaceuticals by pre-empting the selection of certain metal ions/complexes for potential use in these products.

Original languageEnglish (US)
Pages (from-to)69-81
Number of pages13
JournalJournal of Immunotoxicology
Volume3
Issue number2
DOIs
StatePublished - Apr 2006
Externally publishedYes

Fingerprint

Chromium
Metals
Lung
Oxidation-Reduction
Chromates
Coordination Complexes
Solubility
Metal ions
Ions
Vanadium
Health risks
Nickel
Inhalation
Toxicity
Potassium
Iron
Sodium
Research Personnel
Modulation
Oxidation

Keywords

  • Bacterial clearance
  • Chromium
  • Dipic
  • Listeria

ASJC Scopus subject areas

  • Toxicology
  • Immunology
  • Immunology and Allergy

Cite this

Pulmonary immunotoxic potentials of metals are governed by select physicochemical properties : Chromium agents. / Cohen, Mitchell D.; Prophete, Colette M.; Sisco, Maureen; Chen, Lung Chi; Zelikoff, Judith; Smee, Jason J.; Holder, Alvin A.; Crans, Debbie C.

In: Journal of Immunotoxicology, Vol. 3, No. 2, 04.2006, p. 69-81.

Research output: Contribution to journalArticle

Cohen, Mitchell D. ; Prophete, Colette M. ; Sisco, Maureen ; Chen, Lung Chi ; Zelikoff, Judith ; Smee, Jason J. ; Holder, Alvin A. ; Crans, Debbie C. / Pulmonary immunotoxic potentials of metals are governed by select physicochemical properties : Chromium agents. In: Journal of Immunotoxicology. 2006 ; Vol. 3, No. 2. pp. 69-81.
@article{e1fe52054a6b44ef9711cab08b8e3ca6,
title = "Pulmonary immunotoxic potentials of metals are governed by select physicochemical properties: Chromium agents",
abstract = "Increasing the understanding of how metal ions/complexes react in situ will allow for the improved specificity and controlled toxicity of novel synthetic metallocompounds that will be used as inhaled diagnostics or therapeutics. Our previous work showed that inhalation of select metals (e.g., chromium, vanadium, nickel, iron) caused alterations in lung immune cell function and in local bacterial resistance. The data also suggested that variations in the degree of immuno-modulation induced were not solely dependent on the amount of metal deposited in the lung, but also on the specific compound. If specificity governs immunomodulatory potential, it follows that physicochemical properties inherent to the metal may have a role in the elicited effects. We hypothesize that major determinants of any metal compound's immunomodulatory potential in situ are its redox behavior, valency, and/or solubility. Using changes in local bacterial resistance as an endpoint, differences in immunotoxic potential in the lungs were quantified for a range of chromium agents (insoluble calcium chromate(VI), and soluble sodium chromate(VI), potassium bis(dipicolinato)chromate(III) and sodium bis(dipicolinato)chromate(II)). Results indicated that among the latter three forms of Cr, strongly oxidizing hexavalent Cr (Cr[VI]) had the greatest impact on resistance, while reducing divalent and fairly unreactive trivalent forms of Cr had no effect at an equal exposure level (i.e., 100 μ g Cr/m 3 , 5 hr/d, for 5 d). Insoluble Cr(VI) had a greater effect than its soluble form. When data was analyzed in the context of pre-infection lung Cr burdens, it was seen that immunomodulatory potentials for both Cr(VI) agents did not differ significantly; however, complexes with different oxidation states did induce varying responses, suggesting that differences in potential might be attributed to redox behavior. From this it was concluded that for Cr, certain physicochemical properties are likely more important to any in situ pulmonary immunotoxicity than others (i.e., redox behavior is more critical than solubility). Our findings, in part, will help provide a basis for understanding why certain metals could be a greater health risk than others, even when encountered in equal amounts. This, in turn, will help researchers in the design of inhalable diagnostic/therapeutic metallopharmaceuticals by pre-empting the selection of certain metal ions/complexes for potential use in these products.",
keywords = "Bacterial clearance, Chromium, Dipic, Listeria",
author = "Cohen, {Mitchell D.} and Prophete, {Colette M.} and Maureen Sisco and Chen, {Lung Chi} and Judith Zelikoff and Smee, {Jason J.} and Holder, {Alvin A.} and Crans, {Debbie C.}",
year = "2006",
month = "4",
doi = "10.1080/15476910600718434",
language = "English (US)",
volume = "3",
pages = "69--81",
journal = "Journal of Immunotoxicology",
issn = "1547-691X",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - Pulmonary immunotoxic potentials of metals are governed by select physicochemical properties

T2 - Chromium agents

AU - Cohen, Mitchell D.

AU - Prophete, Colette M.

AU - Sisco, Maureen

AU - Chen, Lung Chi

AU - Zelikoff, Judith

AU - Smee, Jason J.

AU - Holder, Alvin A.

AU - Crans, Debbie C.

PY - 2006/4

Y1 - 2006/4

N2 - Increasing the understanding of how metal ions/complexes react in situ will allow for the improved specificity and controlled toxicity of novel synthetic metallocompounds that will be used as inhaled diagnostics or therapeutics. Our previous work showed that inhalation of select metals (e.g., chromium, vanadium, nickel, iron) caused alterations in lung immune cell function and in local bacterial resistance. The data also suggested that variations in the degree of immuno-modulation induced were not solely dependent on the amount of metal deposited in the lung, but also on the specific compound. If specificity governs immunomodulatory potential, it follows that physicochemical properties inherent to the metal may have a role in the elicited effects. We hypothesize that major determinants of any metal compound's immunomodulatory potential in situ are its redox behavior, valency, and/or solubility. Using changes in local bacterial resistance as an endpoint, differences in immunotoxic potential in the lungs were quantified for a range of chromium agents (insoluble calcium chromate(VI), and soluble sodium chromate(VI), potassium bis(dipicolinato)chromate(III) and sodium bis(dipicolinato)chromate(II)). Results indicated that among the latter three forms of Cr, strongly oxidizing hexavalent Cr (Cr[VI]) had the greatest impact on resistance, while reducing divalent and fairly unreactive trivalent forms of Cr had no effect at an equal exposure level (i.e., 100 μ g Cr/m 3 , 5 hr/d, for 5 d). Insoluble Cr(VI) had a greater effect than its soluble form. When data was analyzed in the context of pre-infection lung Cr burdens, it was seen that immunomodulatory potentials for both Cr(VI) agents did not differ significantly; however, complexes with different oxidation states did induce varying responses, suggesting that differences in potential might be attributed to redox behavior. From this it was concluded that for Cr, certain physicochemical properties are likely more important to any in situ pulmonary immunotoxicity than others (i.e., redox behavior is more critical than solubility). Our findings, in part, will help provide a basis for understanding why certain metals could be a greater health risk than others, even when encountered in equal amounts. This, in turn, will help researchers in the design of inhalable diagnostic/therapeutic metallopharmaceuticals by pre-empting the selection of certain metal ions/complexes for potential use in these products.

AB - Increasing the understanding of how metal ions/complexes react in situ will allow for the improved specificity and controlled toxicity of novel synthetic metallocompounds that will be used as inhaled diagnostics or therapeutics. Our previous work showed that inhalation of select metals (e.g., chromium, vanadium, nickel, iron) caused alterations in lung immune cell function and in local bacterial resistance. The data also suggested that variations in the degree of immuno-modulation induced were not solely dependent on the amount of metal deposited in the lung, but also on the specific compound. If specificity governs immunomodulatory potential, it follows that physicochemical properties inherent to the metal may have a role in the elicited effects. We hypothesize that major determinants of any metal compound's immunomodulatory potential in situ are its redox behavior, valency, and/or solubility. Using changes in local bacterial resistance as an endpoint, differences in immunotoxic potential in the lungs were quantified for a range of chromium agents (insoluble calcium chromate(VI), and soluble sodium chromate(VI), potassium bis(dipicolinato)chromate(III) and sodium bis(dipicolinato)chromate(II)). Results indicated that among the latter three forms of Cr, strongly oxidizing hexavalent Cr (Cr[VI]) had the greatest impact on resistance, while reducing divalent and fairly unreactive trivalent forms of Cr had no effect at an equal exposure level (i.e., 100 μ g Cr/m 3 , 5 hr/d, for 5 d). Insoluble Cr(VI) had a greater effect than its soluble form. When data was analyzed in the context of pre-infection lung Cr burdens, it was seen that immunomodulatory potentials for both Cr(VI) agents did not differ significantly; however, complexes with different oxidation states did induce varying responses, suggesting that differences in potential might be attributed to redox behavior. From this it was concluded that for Cr, certain physicochemical properties are likely more important to any in situ pulmonary immunotoxicity than others (i.e., redox behavior is more critical than solubility). Our findings, in part, will help provide a basis for understanding why certain metals could be a greater health risk than others, even when encountered in equal amounts. This, in turn, will help researchers in the design of inhalable diagnostic/therapeutic metallopharmaceuticals by pre-empting the selection of certain metal ions/complexes for potential use in these products.

KW - Bacterial clearance

KW - Chromium

KW - Dipic

KW - Listeria

UR - http://www.scopus.com/inward/record.url?scp=33745115076&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745115076&partnerID=8YFLogxK

U2 - 10.1080/15476910600718434

DO - 10.1080/15476910600718434

M3 - Article

C2 - 18958687

AN - SCOPUS:33745115076

VL - 3

SP - 69

EP - 81

JO - Journal of Immunotoxicology

JF - Journal of Immunotoxicology

SN - 1547-691X

IS - 2

ER -